0001666071-20-000286.txt : 20201110
0001666071-20-000286.hdr.sgml : 20201110
20201110204752
ACCESSION NUMBER: 0001666071-20-000286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201106
FILED AS OF DATE: 20201110
DATE AS OF CHANGE: 20201110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOMERS KIRK
CENTRAL INDEX KEY: 0001204015
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 201302736
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_160505925820716.xml
FORM 4
X0306
4
2020-11-06
0
0001666071
Cardlytics, Inc.
CDLX
0001204015
SOMERS KIRK
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
0
1
0
0
Chief Legal & Privacy Officer
Common Stock
2020-11-06
4
S
0
10000
88
D
71012
D
Common Stock
2020-11-09
4
M
0
1562
20
A
72574
D
Common Stock
2020-11-09
4
M
0
3906
30.44
A
76480
D
Common Stock
2020-11-09
4
M
0
420
0
A
76900
D
Common Stock
2020-11-09
4
S
0
172
100.27
D
76728
D
Employee Stock Option (Right to Buy)
20.0
2020-11-09
4
M
0
1562
0
D
2026-12-06
Common Stock
1562.0
261
D
Employee Stock Option (Right to Buy)
30.44
2020-11-09
4
M
0
3906
0
D
2027-07-07
Common Stock
3906.0
3907
D
Restricted Stock Units
2020-11-09
4
A
0
420
0
A
Common Stock
420.0
420
D
Restricted Stock Units
2020-11-09
4
M
0
420
0
D
Common Stock
420.0
0
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on November 9, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
The RSUs are immediately vested.
/s/ Kirk L. Somers
2020-11-10